Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 34

1.

Antibiotic exposure and 'response failure' for subsequent respiratory tract infections: an observational cohort study of UK preschool children in primary care.

van Hecke O, Fuller A, Bankhead C, Jenkins-Jones S, Francis N, Moore M, Butler C, Wang K.

Br J Gen Pract. 2019 Aug 12. pii: bjgp19X705089. doi: 10.3399/bjgp19X705089. [Epub ahead of print]

2.

Outcomes Associated with Treatment of Chronic Pain with Tapentadol Compared with Morphine and Oxycodone: A UK Primary Care Observational Study.

Morgan CL, Jenkins-Jones S, Currie C, Baxter G.

Adv Ther. 2019 Jun;36(6):1412-1425. doi: 10.1007/s12325-019-00932-7. Epub 2019 Apr 8.

PMID:
30963513
3.

Hospital admissions for severe infections in people with chronic kidney disease in relation to renal disease severity and diabetes status.

Berni E, Pritchard N, Jenkins-Jones S, Ambery P, Jain M, Jermutus L, Scott LA, Currie CJ.

Endocrinol Diabetes Metab. 2018 Jul 8;1(4):e00029. doi: 10.1002/edm2.29. eCollection 2018 Oct.

4.

Impact of treatment with pioglitazone on stroke outcomes: A real-world database analysis.

Morgan CL, Inzucchi SE, Puelles J, Jenkins-Jones S, Currie CJ.

Diabetes Obes Metab. 2018 Sep;20(9):2140-2147. doi: 10.1111/dom.13344. Epub 2018 Jun 4.

PMID:
29732718
5.

Poor compliance and increased mortality, depression and healthcare costs in patients with congenital adrenal hyperplasia.

Jenkins-Jones S, Parviainen L, Porter J, Withe M, Whitaker MJ, Holden SE, Morgan CL, Currie CJ, Ross RJM.

Eur J Endocrinol. 2018 Apr;178(4):309-320. doi: 10.1530/EJE-17-0895. Epub 2018 Jan 25.

6.

Glucose Control and Weight Change Associated with Treatment with Exenatide Compared with Basal Insulin: A Retrospective Study.

Morgan CL, Qiao Q, Grandy S, Johnsson K, Jenkins-Jones S, Holden S, Currie CJ.

Diabetes Ther. 2018 Feb;9(1):269-283. doi: 10.1007/s13300-017-0359-z. Epub 2018 Jan 9.

7.

The risk of cardiac failure following metal-on-metal hip arthroplasty.

Sabah SA, Moon JC, Jenkins-Jones S, Morgan CL, Currie CJ, Wilkinson JM, Porter M, Captur G, Henckel J, Chaturvedi N, Kay P, Skinner JA, Hart AJ, Manisty C.

Bone Joint J. 2018 Jan;100-B(1):20-27. doi: 10.1302/0301-620X.100B1.BJJ-2017-1065.R1. Erratum in: Bone Joint J. 2018 Sep;100-B(9):1260.

8.

Impact of differing glucose-lowering regimens on the pattern of association between glucose control and survival.

Currie CJ, Holden SE, Jenkins-Jones S, Morgan CL, Voss B, Rajpathak SN, Alemayehu B, Peters JR, Engel SS.

Diabetes Obes Metab. 2018 Apr;20(4):821-830. doi: 10.1111/dom.13155. Epub 2017 Dec 8.

9.

Population-based Clinical Practice Research Datalink study using algorithm modelling to identify the true burden of hidradenitis suppurativa.

Ingram JR, Jenkins-Jones S, Knipe DW, Morgan CLI, Cannings-John R, Piguet V.

Br J Dermatol. 2018 Apr;178(4):917-924. doi: 10.1111/bjd.16101. Epub 2018 Feb 22.

PMID:
29094346
10.

Healthcare resource utilization and related financial costs associated with glucose lowering with either exenatide or basal insulin: A retrospective cohort study.

Holden SE, Morgan CL, Qiao Q, Jenkins-Jones S, Berni ER, Currie CJ.

Diabetes Obes Metab. 2017 Aug;19(8):1097-1105. doi: 10.1111/dom.12916. Epub 2017 Mar 31.

PMID:
28218819
11.

Prevalence, glucose control and relative survival of people with Type 2 diabetes in the UK from 1991 to 2013.

Holden SE, Jenkins-Jones S, Morgan CL, Peters JR, Schernthaner G, Currie CJ.

Diabet Med. 2017 Jun;34(6):770-780. doi: 10.1111/dme.13332. Epub 2017 Mar 9.

PMID:
28173634
12.

Risk of cardiovascular events, arrhythmia and all-cause mortality associated with clarithromycin versus alternative antibiotics prescribed for respiratory tract infections: a retrospective cohort study.

Berni E, de Voogd H, Halcox JP, Butler CC, Bannister CA, Jenkins-Jones S, Jones B, Ouwens M, Currie CJ.

BMJ Open. 2017 Jan 23;7(1):e013398. doi: 10.1136/bmjopen-2016-013398.

13.

Non-Response to Antibiotic Treatment in Adolescents for Four Common Infections in UK Primary Care 1991-2012: A Retrospective, Longitudinal Study.

Berni E, Scott LA, Jenkins-Jones S, De Voogd H, Rocha MS, Butler CC, Morgan CL, Currie CJ.

Antibiotics (Basel). 2016 Jul 4;5(3). pii: E25. doi: 10.3390/antibiotics5030025.

14.

Association between Insulin Monotherapy versus Insulin plus Metformin and the Risk of All-Cause Mortality and Other Serious Outcomes: A Retrospective Cohort Study.

Holden SE, Jenkins-Jones S, Currie CJ.

PLoS One. 2016 May 6;11(5):e0153594. doi: 10.1371/journal.pone.0153594. eCollection 2016.

15.

Comparative estimated effectiveness of antibiotic classes as initial and secondary treatments of respiratory tract infections: longitudinal analysis of routine data from UK primary care 1991-2012.

Berni E, Butler CC, Jenkins-Jones S, de Voogd H, Ouwens M, Morgan CL, Currie CJ.

Curr Med Res Opin. 2016 Jun;32(6):1023-32. doi: 10.1185/03007995.2016.1157459. Epub 2016 Mar 11.

PMID:
26907677
16.

Contemporary Reproductive Outcomes for Patients With Polycystic Ovary Syndrome: A Retrospective Observational Study.

Rees DA, Jenkins-Jones S, Morgan CL.

J Clin Endocrinol Metab. 2016 Apr;101(4):1664-72. doi: 10.1210/jc.2015-2682. Epub 2016 Feb 9.

17.

Glucose-lowering with exogenous insulin monotherapy in type 2 diabetes: dose association with all-cause mortality, cardiovascular events and cancer.

Holden SE, Jenkins-Jones S, Morgan CL, Schernthaner G, Currie CJ.

Diabetes Obes Metab. 2015 Apr;17(4):350-62. doi: 10.1111/dom.12412. Epub 2014 Dec 10.

PMID:
25399739
18.

Antibiotic treatment failure in four common infections in UK primary care 1991-2012: longitudinal analysis.

Currie CJ, Berni E, Jenkins-Jones S, Poole CD, Ouwens M, Driessen S, de Voogd H, Butler CC, Morgan CL.

BMJ. 2014 Sep 23;349:g5493. doi: 10.1136/bmj.g5493.

19.

Can people with type 2 diabetes live longer than those without? A comparison of mortality in people initiated with metformin or sulphonylurea monotherapy and matched, non-diabetic controls.

Bannister CA, Holden SE, Jenkins-Jones S, Morgan CL, Halcox JP, Schernthaner G, Mukherjee J, Currie CJ.

Diabetes Obes Metab. 2014 Nov;16(11):1165-73. doi: 10.1111/dom.12354. Epub 2014 Jul 31.

PMID:
25041462
20.

Combination therapy with metformin plus sulphonylureas versus metformin plus DPP-4 inhibitors: association with major adverse cardiovascular events and all-cause mortality.

Morgan CL, Mukherjee J, Jenkins-Jones S, Holden SE, Currie CJ.

Diabetes Obes Metab. 2014 Oct;16(10):977-83. doi: 10.1111/dom.12306. Epub 2014 May 22.

PMID:
24762119
21.

Association between first-line monotherapy with sulphonylurea versus metformin and risk of all-cause mortality and cardiovascular events: a retrospective, observational study.

Morgan CL, Mukherjee J, Jenkins-Jones S, Holden SE, Currie CJ.

Diabetes Obes Metab. 2014 Oct;16(10):957-62. doi: 10.1111/dom.12302. Epub 2014 May 8.

PMID:
24720708
22.

How many people inject insulin? UK estimates from 1991 to 2010.

Holden SE, Gale EA, Jenkins-Jones S, Currie CJ.

Diabetes Obes Metab. 2014 Jun;16(6):553-9. doi: 10.1111/dom.12260. Epub 2014 Feb 9.

PMID:
24410846
23.

Primary prevention of diabetic retinopathy with fibrates: a retrospective, matched cohort study.

Morgan CL, Owens DR, Aubonnet P, Carr ES, Jenkins-Jones S, Poole CD, Currie CJ.

BMJ Open. 2013 Dec 3;3(12):e004025. doi: 10.1136/bmjopen-2013-004025.

24.

The prevalence and incidence, resource use and financial costs of treating people with attention deficit/hyperactivity disorder (ADHD) in the United Kingdom (1998 to 2010).

Holden SE, Jenkins-Jones S, Poole CD, Morgan CL, Coghill D, Currie CJ.

Child Adolesc Psychiatry Ment Health. 2013 Oct 11;7(1):34. doi: 10.1186/1753-2000-7-34.

25.

External validation of the UKPDS risk engine in incident type 2 diabetes: a need for new type 2 diabetes-specific risk equations.

Bannister CA, Poole CD, Jenkins-Jones S, Morgan CL, Elwyn G, Spasic I, Currie CJ.

Diabetes Care. 2014 Feb;37(2):537-45. doi: 10.2337/dc13-1159. Epub 2013 Oct 2.

PMID:
24089541
26.

The incidence of type 2 diabetes in the United Kingdom from 1991 to 2010.

Holden SH, Barnett AH, Peters JR, Jenkins-Jones S, Poole CD, Morgan CL, Currie CJ.

Diabetes Obes Metab. 2013 Sep;15(9):844-52. doi: 10.1111/dom.12123. Epub 2013 May 16.

PMID:
23675742
27.

Omega-3 Fatty acids and mortality outcome in patients with and without type 2 diabetes after myocardial infarction: a retrospective, matched-cohort study.

Poole CD, Halcox JP, Jenkins-Jones S, Carr ES, Schifflers MG, Ray KK, Currie CJ.

Clin Ther. 2013 Jan;35(1):40-51. doi: 10.1016/j.clinthera.2012.11.008. Epub 2012 Dec 13.

28.

The impact of treatment non-compliance on mortality in people with type 1 diabetes.

Currie CJ, Peyrot M, Morgan CL, Poole CD, Jenkins-Jones S, Rubin RR, Burton CM, Evans M.

J Diabetes Complications. 2013 May-Jun;27(3):219-23. doi: 10.1016/j.jdiacomp.2012.10.006. Epub 2012 Nov 13.

PMID:
23157988
29.

What next after metformin? A retrospective evaluation of the outcome of second-line, glucose-lowering therapies in people with type 2 diabetes.

Morgan CL, Poole CD, Evans M, Barnett AH, Jenkins-Jones S, Currie CJ.

J Clin Endocrinol Metab. 2012 Dec;97(12):4605-12. doi: 10.1210/jc.2012-3034. Epub 2012 Oct 17.

PMID:
23076348
30.

Evaluation of adverse outcome in young women with polycystic ovary syndrome versus matched, reference controls: a retrospective, observational study.

Morgan CL, Jenkins-Jones S, Currie CJ, Rees DA.

J Clin Endocrinol Metab. 2012 Sep;97(9):3251-60. doi: 10.1210/jc.2012-1690. Epub 2012 Jul 5.

PMID:
22767635
31.

The impact of treatment noncompliance on mortality in people with type 2 diabetes.

Currie CJ, Peyrot M, Morgan CL, Poole CD, Jenkins-Jones S, Rubin RR, Burton CM, Evans M.

Diabetes Care. 2012 Jun;35(6):1279-84. doi: 10.2337/dc11-1277. Epub 2012 Apr 17.

32.

Mortality after incident cancer in people with and without type 2 diabetes: impact of metformin on survival.

Currie CJ, Poole CD, Jenkins-Jones S, Gale EA, Johnson JA, Morgan CL.

Diabetes Care. 2012 Feb;35(2):299-304. doi: 10.2337/dc11-1313. Epub 2012 Jan 20.

33.

Weight change in people with type 2 diabetes: secular trends and the impact of alternative antihyperglycaemic drugs.

Morgan CL, Jenkins-Jones S, Evans M, Barnett AH, Poole CD, Currie CJ.

Diabetes Obes Metab. 2012 May;14(5):424-32. doi: 10.1111/j.1463-1326.2011.01552.x. Epub 2012 Jan 17.

PMID:
22192841
34.

Clinical effectiveness of biphasic insulin aspart 30:70 versus biphasic human insulin 30 in UK general clinical practice: a retrospective database study.

Morgan CL, Evans M, Toft AD, Jenkins-Jones S, Poole CD, Currie CJ.

Clin Ther. 2011 Jan;33(1):27-35. doi: 10.1016/j.clinthera.2011.01.023. Erratum in: Clin Ther. 2011 Mar;33(3):391.

PMID:
21397771

Supplemental Content

Loading ...
Support Center